Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $300M+, returning 13,365.6%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 13,365.57% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 4,726.29% |
DeFi Development (DFDV) | 2,300.06% |
Zepp Health (ZEPP) | 1,893.85% |
Abivax SA American Depositary Shares (ABVX) | 1,220.86% |
Oncology Institute (TOI) | 1,190.85% |
Nanobiotix (NBTX) | 874.6% |
United States Antimony (UAMY) | 838.76% |
TMC the metals (TMC) | 837.72% |
Oklo (OKLO) | 705.51% |
Airnet Technology (ANTE) | 627.88% |
NioCorp Developments Ltd Common Stock (NB) | 611.95% |
I-Mab (IMAB) | 581.18% |
IREN (IREN) | 522.11% |
ThredUp (TDUP) | 519.44% |
Mobilicom Limited Warrants (MOBBW) | 519.39% |
Newegg Commerce (NEGG) | 510.88% |
IsoEnergy (ISOU) | 508.56% |
Sify Technologies (SIFY) | 506.64% |
MP Materials (MP) | 499.75% |
Centrus Energy (LEU) | 493.51% |
Avino Silver & Gold Mines (ASM) | 486.81% |
Trilogy Metals (TMQ) | 465.52% |
Better Home & Finance (BETR) | 455% |
